• Article

Risk of autoimmune dseases (AD) after human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine immunization in women aged 9 to 25 years in the United Kingdom An observational cohort study

(Meeting Abstract 717)

Citation

Willame, C., Rosillon, D., Zima, J., Angelo, MG., Stuurman, A., Vroling, H., ... Baril, L. (2015). Risk of autoimmune dseases (AD) after human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine immunization in women aged 9 to 25 years in the United Kingdom: An observational cohort study. Pharmacoepidemiology and Drug Safety, 24(Supplement: 1), 409.